Qiagen Story

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;'>QN</div>
QGEN -- USA Stock  

USD 52.24  0.73  1.42%

Given the investment horizon of 90 days, Qiagen NV is expected to generate 0.82 times more return on investment than the market. However, the company is 1.22 times less risky than the market. It trades about 0.2 of its potential returns per unit of risk. The DOW is currently generating roughly 0.14 per unit of risk. As many old-fashioned traders are trying to avoid healthcare space, it makes sense to outline Qiagen NV a little further and try to understand its current volatility patterns. We will go over odds for Qiagen NV to generate above-average margins next month. Qiagen NV's very low volatility may have no significant impact on the stock's value as we estimate Qiagen NV as currently overvalued. The real value, based on our calculations, is getting close to 42.22 per share.
Published over a month ago
View all stories for Qiagen NV | View All Stories
Is Qiagen NV (NYSE:QGEN) positioned to overcome the latest market swings?
The company conducts business under Healthcare sector and is part of Diagnostics & Research industry.
Volatility is a rate at which the price of Qiagen NV or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Qiagen NV may increase or decrease. In other words, similar to Qiagen's beta indicator, it measures the risk of Qiagen NV and helps estimate the fluctuations that may happen in a short period of time. So if prices of Qiagen NV fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility. Please read more on our technical analysis page.

How important is Qiagen NV's Liquidity

Qiagen NV financial leverage refers to using borrowed capital as a funding source to finance Qiagen NV ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Qiagen NV financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Qiagen NV's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions. It is good to see analyst projects for Qiagen NV, but it might be worth checking our own buy vs. sell analysis

What is driving Qiagen NV Investor Appetite?

The latest bullish price patterns experienced by current Qiagen NV shareholders created some momentum for institutional investors as it was traded today as low as 49.29 and as high as 51.07 per share. The company directors and management have been very successful in rebalancing the company assets at opportune times to take advantage of market volatility in July. The stock standard deviation of daily returns for 30 days investing horizon is currently 1.23. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.

Qiagen is expecting lower volatility in September

Qiagen NV total risk alpha is up to -0.01. Qiagen NV has low volatility with Treynor Ratio of 10.95, Maximum Drawdown of 5.92 and kurtosis of 2.59. However, we advice all investors to further analyze Qiagen NV to make certain all market information is desiminated and is consistent with the current expectations about Qiagen NV upside potential.

Our Conclusion on Qiagen NV

Whereas other companies under the diagnostics & research industry are still a bit expensive, Qiagen NV may offer a potential longer-term growth to institutional investors. The inconsistency in the assessment between current Qiagen valuation and our trade advice on Qiagen NV is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Qiagen NV.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Qiagen NV. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com